Hologic Pops on Q1 Earnings Beat

Shares of Hologic HOLX are trading higher in the after-hours following the release of the company's Q1 earnings results. Currently, shares are higher by 1.77%, trading at $19.54; they ended the regular session lower by 0.93%, at $19.20. Hologic reported Q1 EPS of $0.34 on revenues of $472.7 million; the Street was looking for $0.32 per share on revenues of $466.4 million. Revenues increased 9.3% year over year. Revenues of $472.7 million resulting from year-over-year growth in all four operating segments. The company sees Q2 EPS of $0.33 on revenues of $470-475 million; the Street was looking for $0.33 per share on revenues of $470.84 million. The company's guidance reflects its current core products, including revenues from its approved/cleared products and its recently acquired businesses, but does not reflect any revenue or earnings from future acquisitions, if any. Hologic, Inc. is a developer, manufacturer and supplier of diagnostics, medical imaging systems and surgical products for the healthcare needs of women.